Key result
Nonobese women with PCOS showed no significant differences in omentin or vaspin levels compared to controls, but had significantly higher insulin, testosterone, and triglycerides.
Why the study?
Do plasma levels of omentin and vaspin differ between nonobese women with PCOS and healthy controls?
Case-Control (n=78)
Do plasma levels of omentin and vaspin differ between nonobese women with PCOS and healthy controls?
In nonobese women, PCOS is not associated with decreased omentin and vaspin plasma levels, but is characterized by high androgen levels and insulin resistance.
Answers are grounded in this paper and cite their sources.
Omentin and vaspin levels should not yet inform nonobese PCOS assessment; leaves open their role in obese or insulin-resistant subgroups.
Polycystic ovary syndrome (PCOS) is an endocrine disorder in women. Omentin-1 and vaspin are secretary adipokines that are produced by the visceral adipose tissue. These levels change in obese women with PCOS. The aim of this study is to investigate whether omentin and vaspin levels change in nonobese PCOS subjects. This study is a cross-sectional case control study in which 39 women with PCOS were picked out for this study. The inclusion criteria were based on the Rotterdam 2003 diagnostic criteria. The control group consisted of 39 women with normal pelvic sonographic reports having regular menstruation and showing no signs of infertility. The fasting plasma glucose (FPG), triglyceride (TG), Chol, and high-density lipoprotein cholesterol (HDL-C), insulin, testosterone, omentin and vaspin were measured by the enzymatic methods. The differences within these groups were calculated by the un-paired t-test and the Mann-Whitney test. The results from this study show a significant increase in the amount of insulin, testosterone, homeostasis model assessments for insulin resistance, TG and lower HDL in the patient group. No significant differences were seen in omentin, vaspin, FPG, Cho, low-density lipoprotein, very low-density lipoprotein cholesterol, blood urea nitrogen, Cr and homeostasis model assessments for B cell function levels between groups. Results show that PCOS is not a determinant of decreased omentin and vaspin plasma levels and those high androgen level and insulin resistances are warning signs of PCOS.
No takes yet. Share an insight, caveat, or question.
Akbarzadeh et al. (2012) conducted a case-control in Polycystic ovary syndrome (PCOS) (n=78). Polycystic ovary syndrome (PCOS) vs. Healthy women with normal pelvic sonographic reports, regular menstruation, and no signs of infertility was evaluated on Plasma levels of omentin and vaspin. Nonobese women with PCOS showed no significant differences in omentin or vaspin levels compared to controls, but had significantly higher insulin, testosterone, and triglycerides.
Synapse has enriched 10 related papers. Consider them for comparative context: